Hepatitis C virus infection: Epidemiology in Egypt, Pathophysiology and DAAs-based therapy

Efficacy of Sofosbuvir plus Daclatasvir in Treatment of Chronic HCV Infection in Egyptian Patients: A Prospective Cohort Study

Impact of direct-acting antiviral therapy in Egyptian patients with chronic hepatitis C and liver cirrhosis

Occurrence and Recurrence of Hepatocellular Carcinoma after Direct Acting Antivirals in Compensated Chronic Hepatitis (C) Cirrhotic Egyptian Patients

Assessment of Haematological and Immunological Effect after New Direct ‎Acting Antiviral Drugs in Chronic Hepatitis C Virus Egyptian Patients

Frequency of Hepatocellular Carcinoma in Cirrhotic Patients after Chronic Hepatitis C Infection Treatment with Direct-Acting ‎Antivirals

Impact of long-term eradication of chronic Hepatitis C infection using the direct-acting antiviral treatment on liver fibrosis parameters in Egyptian patients

Assessment of Incidence of Hepatocellular Carcinoma among Hepatitis C Patients Who Achieved Sustained Virological Response with Direct Acting Antiviral Agents (DAAs)

Cost-Effectiveness of HCV Core Antigen versus PCR for Monitoring Treatment Response in DAAS-Treated Egyptian Patients

SAFETY AND EFFICACY OF DIRECTLY ACTING ANTIVIRAL DRUGS IN TREATMENT OF CHRONIC HCV EGYPTIAN PATIENTS